Andrew Sternlicht
Corporate Officer/Principal presso Tufts University
Profilo
Andrew Sternlicht is Vice President of Medical Affairs and Corporate Development for ActivBiotics, Inc. and a Principal of St. Elizabeth's Medical Center.
He is an Assistant Professor at Tufts University School of Medicine.
Dr. Sternlicht has been an Industry Consultant and was a Member on the Strategic Advisory Boards of Baxter Corp., Elan Corp.
Plc, Algos Pharmaceutical Corp.
and Vital Signs, Inc. Prior to joining ActivBiotics, he was an Executive Medical Director for Angiomax.
Dr. Sternlicht received an MD from Yale and an MA degree in Biology from the University of Pennsylvania.
Posizioni attive di Andrew Sternlicht
| Società | Posizione | Inizio |
|---|---|---|
| Tufts University | Corporate Officer/Principal | - |
Precedenti posizioni note di Andrew Sternlicht
| Società | Posizione | Fine |
|---|---|---|
Vital Signs, Inc.
 Vital Signs, Inc. Medical SpecialtiesHealth Technology Vital Signs, Inc. was manufacturing patented products for the use in anesthesia and other related critical care procedures. The company was founded in 1972 and was headquartered in Totowa, NJ. | Corporate Officer/Principal | - |
Algos Pharmaceutical Corp.
 Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Corporate Officer/Principal | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Baxter Corp.
 Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Corporate Officer/Principal | - |
| St. Elizabeth's Medical Center | Corporate Officer/Principal | - |
Formazione di Andrew Sternlicht
| Yale University | Doctorate Degree |
| University of Pennsylvania | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Health Technology |
| St. Elizabeth's Medical Center | Health Services |
Baxter Corp.
Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Health Technology |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Algos Pharmaceutical Corp.
Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Health Technology |
Vital Signs, Inc.
Vital Signs, Inc. Medical SpecialtiesHealth Technology Vital Signs, Inc. was manufacturing patented products for the use in anesthesia and other related critical care procedures. The company was founded in 1972 and was headquartered in Totowa, NJ. | Health Technology |
- Borsa valori
- Insiders
- Andrew Sternlicht